Live Breaking News & Updates on Biosimilars Biosimilars
Stay updated with breaking news from Biosimilars biosimilars. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Protects access to new medicines and cures and lowers out of pocket spending and strengthens transparency and accountability and champions competition. H. R. 19 acts in the interest of hardworking americans. I urge my colleagues to support this bipartisan, commonsense amendment. I yield back. The chair the gentlewoman from california is recognized. Ms. Porter claims that h. R. 3 ill stop cures is fear mongering. H. R. 3 makes substantial more ment to help create cures and most importantly will make sure those cures can actually help people in their lives. Fair that the government, elected by the taxpayers, and the appointed by , elected officials, should get to negotiate drug prices, and it not come at the expense of innovation. I reserve the balance of my time. He chair the gentlewoman reserves. The gentleman from oregon. Mr. Walden i reserve. The chair the gentleman reserves. California man from is recognized. Speaker, how r. Much time remains . The chair the gentlewoman has 30 secon ....
Hepatitis c, diabetes and oncology are the primary drivers of the spending growth. Prescription growth is 1. 2 for the year. That is a substantial reduction from last year. The primary effect is the rescheduling of hydrocodone to more restrictive schedule which cut that market by 30 . And also you have more chronic care prescriptions are 90day prescriptions. 75 is on specialists. You cant look at that market here or everywhere around the World Without talking specialty. And next year we expect crestor to go off. So these are whats driving spending growth. You can see hepatitis at the top followed by diabetes, oncology, autoimmune, multiple sclerosis, hiv, respiratory, nervous system, and so forth. Almost all of the big five are in the specialty area. And if you look closely at the slide, and i assume youll get copies of this later, what the significant impacts are in each of these things and we break it down by new brands, whats go ....